Metrion Biosciences Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 25
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $3.86M
Latest Deal Amount
  • Investors
  • 5

Metrion Biosciences General Information

Description

Operator of a contract research organization (CRO) intended to focus on delivering a range of ion channel drug discovery services. The company's platform provides highly skilled electrophysiology screening services, it also offers flexible business models according to the scope of each program, with both fee-for-service and collaborative options and options to access integrated drug discovery services, enabling clients with the support of medicinal chemistry optimization programs, CiPA compliant cardiac safety profiling assays, neuroscience assays, and translational assays.

Contact Information

Website
www.metrionbiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Consulting Services (B2B)
Practice Management (Healthcare)
Primary Office
  • Building 2 Granta Centre Great Abington
  • First Floor
  • Cambridge CB21 6AL
  • England, United Kingdom
+44 01223 000000

Metrion Biosciences Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Metrion Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 06-Apr-2021 $3.86M 00.00 000.00 Completed Generating Revenue
11. Grant 01-Oct-2020 000.00 00.000 Completed
10. Grant 01-Jun-2020 0000 00.000 Completed
9. Grant 01-Jul-2019 000.00 00.000 Completed
8. Early Stage VC 01-Apr-2019 00000 00.000 00.000 Completed Generating Revenue
7. Grant 01-Sep-2018 00000 00.000 Completed
6. Grant 28-Aug-2018 00.000 00.000 Completed Generating Revenue
5. Early Stage VC 30-Apr-2018 00.000 00.000 00.000 Completed Generating Revenue
4. Grant 01-Feb-2018 $194K Completed
3. Grant 04-Apr-2016 Completed Startup
To view Metrion Biosciences’s complete valuation and funding history, request access »

Metrion Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
A Preference 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 191,125 $0.013847 $6.92 $6.92 1x $6.92 18.52%
Ordinary 244,200 $0.013847 $1.38 $1.38 1x $1.38 23.66%
To view Metrion Biosciences’s complete cap table history, request access »

Metrion Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a contract research organization (CRO) intended to focus on delivering a range of ion channel drug discovery
Drug Discovery
Cambridge, United Kingdom
25 As of 2021
00.00
00.00 0000-00-00
0000000000 0 00.00

00000000

on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit i
0000 000000000
Essex, United Kingdom
00 As of 0000
000
00000000000 000

0000

te irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exce
000000000000000
Shanghai, China
0000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Metrion Biosciences Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Domainex Venture Capital-Backed Essex, United Kingdom 00 000 00000000000 000
0000 Venture Capital-Backed Shanghai, China 0000 00000 00000000000 00000
0000 000000 Formerly PE-Backed Shanghai, China 00000 00.000 000000000 00.000
000000 Formerly PE-Backed Hamburg, Germany 0000 00000 000000000 00000
To view Metrion Biosciences’s complete competitors history, request access »

Metrion Biosciences Patents

  • 24

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Metrion Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3817742-A1 Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof Pending 06-Jul-2018 00000000000
CA-3105757-A1 Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof Pending 06-Jul-2018 00000000000
AU-2019298758-A1 Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof Pending 06-Jul-2018 00000000000
GB-201811165-D0 Novel compounds Ceased 06-Jul-2018 0000000000
US-20210275499-A1 Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof Pending 06-Jul-2018 C07D233/28

Metrion Biosciences Executive Team (6)

Name Title Board Seat Contact Info
Andrew Southan Ph.D Chief Executive Officer & Executive Director
Marc Rogers Ph.D Co-Founder, Chief Scientific Officer & Board Member
Nick Foster Chief Commercial Officer & Head of Global Business Development
John Ford Ph.D Board Member & Investor Director
Keith McCullagh Ph.D Co-Founder & Chairman
You’re viewing 5 of 6 executive team members. Get the full list »

Metrion Biosciences Board Members (9)

Name Representing Role Since
Barry Kenny Ph.D Self Board Member 000 0000
John Ford Ph.D Self Board Member & Investor Director 000 0000
John Montana Ph.D Self Board Member 000 0000
Keith McCullagh Ph.D Self Co-Founder & Chairman 000 0000
Marc Rogers Ph.D Metrion Biosciences Co-Founder, Chief Scientific Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Metrion Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Metrion Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Gresham House Ventures Asset Manager Minority 000 0000 000000 0
O2h Ventures Venture Capital Minority 000 0000 000000 0
Biomedical Catalyst Government 000 0000 000000 0
Eurostars Government 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
To view Metrion Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial